Life Science-podden: The perfect moment for an IPO

When is the right time to go for an IPO? What strategy is recommended in today´s rather uncertain business climate when it comes to taking your life science company public?

Join us for a Life Science seminar on april 9th on GoCo

Festo products and solutions are setting the stage for better health through innovative solutions for reliable medical technology and precise, reproducible labo...

Anocca raises SEK 440 million ahead of clinical cancer trial

Swedish cell therapy biotech Anocca has successfully raised SEK 440 million in a new funding round to support upcoming clinical trials in pancreatic cancer.

FDA plans to replace animal testing with AI – “Paradigm shift”

The requirement for animal testing in drug development will be phased out and replaced by AI, according to an announcement by the FDA. The decision has been met...

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

“We should avoid surgery if we can”

Since February this year, she has been Scientific Director Life Science at the Karolinska Institutet. Life Science Sweden met Anna Martling for a talk about rol...

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Sahlgrenska och Astra Zeneca i nytt samarbete

Främja utvecklingen av innovativa läkemedel. Det är syftet med ett nytt samarbete mellan Sahlgrenska universitetssjukhuset och Astra Zeneca.

The New Precise Magazine is Available Now

Download the new issue.

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

FDA beviljar prioritetsgranskning av Astra Zenecas Tagrisso

Den amerikanska läkemedelsmyndigheten FDA har accepterat och beviljat prioritetsgranskning av Astra Zeneceas NDA-ansökan för Tagrisso för behandling av vuxna me...

Fördjupat samarbete ska stärka Göteborgs life science-kluster

Göteborg är hemvist för ett av de största hälso-klustren i Norden – men vill växa och bli ännu vassare. Nu inleder Astra Zeneca och Business Region Göteborg ett...

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...

Bioarctics forskningschef Johanna Fälting tar plats i VR:s ämnesråd

Bioarctics forskningschef Johanna Fälting och läkaren Markus Lingman har utsetts till nya ledamöter i Vetenskapsrådets ämnesråd för medicin och hälsa.

Positive trend for Swedish medtech exports – “We have new markets that are huge”

In 2024, Swedish exports of pharmaceuticals decreased for the first time in several years. However, the trend for medical technology looks brighter. During a se...

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

Biogen's Alzheimer's candidate BIIB080 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

Läkemedelsjättar vill stanna i EU – ber kommissionen om hjälp

Astra Zeneca har tillsammans med nästan tre dussintals globala läkemedelsbolag uttryckt sin önskan att förbli kvar i Europa, men då vill man ha hjälp av EU-komm...

Nytt USA-godkännande för Astra Zeneca

Astra Zenecas läkemedel Enhertu är nu godkänd för ytterligare en indikation i USA.

It couldn’t be simpler

AI-assisted ZEISS Solution inspects implant coatings automatically.

Scientific Solutions

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”

A new cell therapy for leukaemia, a vaccine in tablet form against cholera, and a proprietary mRNA line with the potential capacity to supply the entire Nordic ...

Gothenburg, the city of life science – We are ‘Little Boston’

Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...